• Home
  • Pharmacy Medical Policy Updates

Pharmacy Medical Policy Updates

The following Pharmacy Medical Policy programs have been updated today, March 1, 2021:

Effective April 1, 2021:

  • Biologic Immunomodulators
  • Multiple Sclerosis
  • Multiple Sclerosis IV
  • Afrezza
  • GLP1
  • Insulin
  • Insulin Combination
  • Methotrexate Injectable
  • CFTR
  • Hereditary Angioedema
  • Interstitial Lung Disease (ILD)

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization

If you have any questions regarding this publication, please contact your BCBSKS provider representative/consultant.

Institutional Providers
Professional Providers